Pacer Advisors, Inc. Uni Qure N.V. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2022	SELL	$14.54 - $21.5 $4.26 Million - $6.3 Million	-292,869 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$20.24 - $36.01 $2.55 Million - $4.53 Million	125,809 Added 75.31%	292,869 $6.07 Million
Q3 2021 Oct 15, 2021	BUY	$26.01 - $38.22 $4.35 Million - $6.39 Million	167,060 New	167,060 $5.35 Million
Q2 2021 Jul 21, 2021	SELL	$29.97 - $37.17 $68,811 - $85,342	-2,296 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$29.24 - $42.03 $6,549 - $9,414	224 Added 10.81%	2,296 $77,000
Q4 2020 Jan 20, 2021	BUY	$35.35 - $50.67 $73,245 - $104,988	2,072 New	2,072 $75,000

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $290M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.